EUVIMEDEUVIMED entdecken
Crossref

Overcoming Formulation Challenges Across Molecular Classes: Rapid FAST Nanoformulation of BCS Class II/IV Drugs and Therapeutic Peptides

Stephen Hsu, Hongfang Yu, Archith Philip, Amani Mouna, Ashish K. Sarker, Brendan Marshall, Douglas Dickinson

Fortune Journal of Health Sciences · 2026 · 9 (4)

DOI: 10.26502/fjhs.452 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Fortune Journal of Health Sciences, 2026. Verfasst von Stephen Hsu und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Hsu, S., Yu, H., Philip, A., Mouna, A., Sarker, A. K., Marshall, B., & Dickinson, D. (2026). Overcoming Formulation Challenges Across Molecular Classes: Rapid FAST Nanoformulation of BCS Class II/IV Drugs and Therapeutic Peptides. Fortune Journal of Health Sciences, 9(4). https://doi.org/10.26502/fjhs.452

Vancouver

Hsu S, Yu H, Philip A, Mouna A, Sarker AK, Marshall B, et al. Overcoming Formulation Challenges Across Molecular Classes: Rapid FAST Nanoformulation of BCS Class II/IV Drugs and Therapeutic Peptides. Fortune Journal of Health Sciences. 2026;9(4). doi:10.26502/fjhs.452

BibTeX
@article{Hsu2026,
  author = {Hsu, Stephen and Yu, Hongfang and Philip, Archith and Mouna, Amani and Sarker, Ashish K. and Marshall, Brendan and Dickinson, Douglas},
  title = {Overcoming Formulation Challenges Across Molecular Classes: Rapid FAST Nanoformulation of BCS Class II/IV Drugs and Therapeutic Peptides},
  journal = {Fortune Journal of Health Sciences},
  year = {2026},
  volume = {9},
  number = {4},
  doi = {10.26502/fjhs.452}
}
Kostenlos starten →